Contents

Search


drug adverse effects of parasympatholytics

Adverse effects: 1) dry skin, dry mucous membrames, dry mouth 2) mydriasis, blurred vision 3) urinary retention - risk of acute urinary retention greatest in 1st 30 days of therapy [4] 4) constipation 5) abdominal pain 6) tachycardia 7) dizziness 8) drowsiness 9) nausea 10) confusion, delirium 11) hyperthermia 12) thirst 13) chronic use may increase risk of dementia [1,5] 14) use of anticholinergics by cognitively nornal elderly is associated with increased brain atrophy & dysfunction & clinical decline [4] 15) withdrawal: abrupt cessation can lead to cholinergic rebound symptoms, - agitation, diarrhea, vomiting, tachycardia, & insomnia [6]

Properties

DRUGS: parasympatholytic FORM: drug adverse effects parasympatholytic

References

  1. Carriere I et al Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: The 3-city study. Arch Intern Med 2009 Jul 27; 169:1317. PMID: 19636034
  2. Martin-Merino E et al. Do oral antimuscarinic drugs carry an increased risk of acute urinary retention? J Urol 2009 Oct; 182:1442. PMID: 19683302
  3. Medical Knowledge Self Assessment Program (MKSAP) 15, American College of Physicians, Philadelphia 2009
  4. Risacher SL, McDonald BC, Tallman EF et al Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults. JAMA Neurol. 2016 Jun 1;73(6):721-32. PMID: 27088965
  5. Richardson K, Fox C, Maidment I et al Anticholinergic drugs and risk of dementia: case-control study. BMJ 2018;361:k1315 PMID: 29695481 Free PMC Article https://www.bmj.com/content/361/bmj.k1315 - Gray SL, Hanlon JT Anticholinergic drugs and dementia in older adults BMJ 2018;361:k1722 PMID: 29695471 https://www.bmj.com/content/361/bmj.k1722
  6. Geriatric Review Syllabus, 11th edition (GRS11) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2022
  7. Cross AJ, George J, Woodward MC et al Potentially Inappropriate Medications and Anticholinergic Burden in Older People Attending Memory Clinics in Australia. Drugs Aging. 2016 Jan;33(1):37-44 PMID: 2664529
  8. Reppas-Rindlisbacher CE, Fischer HD, Fung K et al Anticholinergic Drug Burden in Persons with Dementia Taking a Cholinesterase Inhibitor: The Effect of Multiple Physicians. J Am Geriatr Soc. 2016;64(3):492-500 PMID: 27000323 PMCID: PMC4819524 Free PMC article